liver tumors
Our results are consistent with the tumor target specificity of PhIP and MeIQx and with increased susceptibility to MeIQx-induced liver tumors in rapid NAT2 acetylators.
Our results are consistent with the tumor target specificity of PhIP and MeIQx and with increased susceptibility to MeIQx-induced <span class="disease" id="19666988-9-130-142">liver tumors</span> in rapid <span class="gene" id="19666988-9-152-156">NAT2</span> acetylators.